Testoviron-depot

combination of testosterone propionate & testosterone enanthate

Also Known As:

Testenate; Testoviron Depot

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Pharmaceutical Preparations
- Drug Combinations: 5337
  - Testoviron-depot: 8
Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Androstanes: 11
      - Androstenes: 5
        Androstenols
        Testosterone: 20642
        Testoviron-depot: 8
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gonadal Hormones: 716
    - Gonadal Steroid Hormones: 7657
      - Testosterone Congeners: 112
        Testosterone: 20642
        Testoviron-depot: 8

Experts

1.	Reshma Anjum, M: 1 article (06/2015)
2.	Sreenivasula Reddy, P: 1 article (06/2015)
3.	Baldassarre, M: 1 article (09/2013)
4.	Battaglia, C: 1 article (09/2013)
5.	Busacchi, P: 1 article (09/2013)
6.	Foschini, M P: 1 article (09/2013)
7.	Giannone, F A: 1 article (09/2013)
8.	Meriggiola, M C: 1 article (09/2013)
9.	Venturoli, S: 1 article (09/2013)
10.	Casadio, Paolo: 1 article (11/2009)

Related Diseases

1.	Body Weight (Weight, Body) 06/01/2015 - "Lead acetate was administered orally to adult male rats (95 ± 5 days) at dosage level of 0.05 and 0.15% for 55 days through drinking water and injected intraperitoneally with either testoviron depot at a dose of 4.16 mg kg(-1) body weight or vehicle alone on days 1, 7 and 14 respectively. " 06/01/1993 - "The test consisted of determination of the decline in plasma level of sex hormone binding globulin (SHBG) on the 7th day after administration of a single dose of testosterone preparation (Testoviron Depot 100, Schering, 2 mg/kg body weight). " 09/01/1992 - "The test is based on determination of sex hormone-binding globulin (SHBG) following single administration of testosterone preparation (Testoviron Depot, Schering, 2 mg/kg of body weight). "
2.	Prolapse 09/01/2013 - "Vaginal tissue samples from 16 FtM subjects treated with T (intramuscular injections of 100 mg Testoviron Depot/7-10 days for at least 1 year), undergoing sex reassignment surgery, and 16 PrM and 16 M subjects undergoing a vaginal hysterectomy for prolapse, were collected. "
3.	Neoplasms (Cancer) 11/01/1983 - "The administration of testenate 7-10 days before the start and during radiotherapy proved to be effective which was confirmed by noticeable necrobiotic and necrotic changes of cancer cells."
4.	Infertility (Sterility) 11/01/2009 - "Endometrial samples from 27 FtM treated with T (intramuscular injection of 100 mg Testoviron Depot /10 days for at least one year), 30 M undergoing vaginal hysterectomy, and 13 PM undergoing hysteroscopy for infertility problems were collected. "
5.	Epilepsy (Aura) 01/01/1991 - "[Effect of testenate in the treatment of epilepsy in men]."

Related Drugs and Biologics

1.	Testosterone (Sustanon)
2.	Sex Hormone-Binding Globulin
3.	Drinking Water
4.	lead acetate

Related Therapies and Procedures

1.	Intramuscular Injections
2.	Vaginal Hysterectomy
3.	Sex Reassignment Surgery
4.	Radiotherapy